Sangamo Therapeutics Inc (SGMO) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sangamo Therapeutics Inc   (NASDAQ: SGMO)


Sangamo Therapeutics Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sangamo Therapeutics Inc's ROI in the first quarter of 2026?
Sangamo Therapeutics Inc recorded a cumulative net loss of $-123 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -438.4%.

Within the Healthcare sector 765 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 3736 to 3761.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -47.55 % -46.64 % -44.93 % -51.24 % -66.93 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 7 17 39 50 37
Return On Investment (TTM) -438.4 % -345.56 % -238.03 % -120.34 % -148.13 %
SGMO's Overall Ranking # 3761 # 3736 # 4060 # 3678 # 3895
Seq. Investment Change TTM -20.92 % -21.32 % -14.06 % -1.92 % -19.54 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -123 -123 -108 -63 -79

SGMO Company Profile >> Back to SGMO Roi Comparisons >> See Annual SGMO Return On Investment



Return On Investment SGMO's Ranking
Within: No.
Industry # 117
Sector # 766
Overall # 3761

Return On Investment Statistics
High Average Low
-10.71 %
-64.4 %
-438.4 %
(March 31, 2015)   (Mar 31 2026)







Financial Statements
Sangamo Therapeutics Inc's I. Quarter Investments $ 7 Millions SGMO's Balance sheet
Sangamo Therapeutics Inc's I. Quarter Income $ -31 Millions Quarterly SGMO's Income Statement
SGMO's Income by Division See SGMO's Income by Division


SGMO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 17 56 118 451 594
Y / Y Investment Growth -69.05 % -52.52 % -73.92 % -24.11 % -25.2 %
Net Income in Millions -123 -98 -258 -192 -178
Y / Y Net Income Growth - - - - -
Annual Return On Investment -711.45 % -175.43 % -219.26 % -42.65 % -30.01 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SGMO's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SGMO's Competitors
Subscribers only: Roi for Sangamo Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for SGMO's Customers

Other Ratios
SGMO's Roa SGMO's Inventory Turnover Ratio SGMO's Growth Rates SGMO's Dividend Statistics
SGMO's Profitability Ratios SGMO's Asset Turnover Ratio SGMO's Dividend Growth
SGMO's Roe SGMO's Valuation Ratios SGMO's Financial Strength Ratios SGMO's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.